Adaptive Biotechnologies (ADPT) shares outstanding

Shares outstanding · fiscal 2025
151.72M

Adaptive Biotechnologies (ADPT) had 151.72M diluted shares on average in fiscal 2025 (the year ended December 31, 2025). That is 3.1% higher than the 147.10M of fiscal 2024. Figures as of 18 Nov 2026, 12:10 UTC, from the company's filings with the SEC and Yahoo Finance.

Key facts

Shares outstanding, fiscal 2025
151.72M
Change on fiscal 2024
+3.1%
Growth, 5 years
+2.9% a year
Highest on record
151.72Mfiscal 2025
Lowest on record
131.22Mfiscal 2020
Fiscal years on record
62020–2025

Figures as of . Older fiscal years come from the company's filings with the SEC, recent ones from Yahoo Finance. Figures, not advice.

Adaptive Biotechnologies shares outstanding, in more detail

The market data feed counts 161.88M shares outstanding today.

Over the five fiscal years to 2025 the diluted share count grew at a compound 2.9% a year. Across the 6 fiscal years on record (2020–2025), the highest was 151.72M in fiscal 2025 and the lowest 131.22M in fiscal 2020.

History · 6 fiscal years

Shares outstanding by fiscal year

Adaptive Biotechnologies shares outstanding, year by year

Adaptive Biotechnologies (ADPT) shares outstanding by fiscal year
Fiscal yearShares outstandingChangeYear ended
2025151.72M 3.1% up
2024147.10M 1.9% up
2023144.38M 1.3% up
2022142.52M 1.5% up
2021140.35M 7.0% up
2020131.22M—

Change is on the fiscal year before; a dash means that year is not on record or the earlier figure was not positive. A dash anywhere else means the figure was not reported or cannot be computed — it is never filled in.

Method

How it is calculated

The share count for each fiscal year is the diluted weighted average the company reports with its earnings per share, re-based for later stock splits; the number outstanding today comes from the market data feed.

How to read it

A falling count means buybacks are giving each remaining share a larger slice of the company; a rising one means owners are being diluted.

Shares outstanding at health care companies of similar size

Shares outstanding of Adaptive Biotechnologies and comparable companies
CompanyShares outstandingFiscal year
Dianthus Therapeutics DNTH38.62M2025
MiniMed Group MMED256.60M2026
Adaptive Biotechnologies ADPT151.72M2025
Heartflow HTFL36.85M2025
CRISPR Therapeutics CRSP89.93M2025
Travere Therapeutics TVTX89.21M2025

The latest fiscal year on record for each company, in the currency it reports in. Fiscal years end at different times of year.

More on ADPT

Adaptive Biotechnologies, figure by figure

Adaptive Biotechnologies (ADPT) overview: price, valuation and scorecardAll health care companies by market value

Adaptive Biotechnologies shares outstanding: questions and answers

How many shares does Adaptive Biotechnologies have?

Adaptive Biotechnologies (ADPT) had 151.72M diluted shares on average in fiscal 2025 (the year ended December 31, 2025). That is 3.1% higher than the 147.10M of fiscal 2024. The market data feed counts 161.88M shares outstanding today.

What is the growth rate of Adaptive Biotechnologies's diluted share count?

Over the five fiscal years to 2025 the diluted share count grew at a compound 2.9% a year.

What are the highest and lowest diluted share count figures on record for Adaptive Biotechnologies?

Across the 6 fiscal years on record (2020–2025), the highest was 151.72M in fiscal 2025 and the lowest 131.22M in fiscal 2020.

How is Adaptive Biotechnologies's diluted share count calculated?

The share count for each fiscal year is the diluted weighted average the company reports with its earnings per share, re-based for later stock splits; the number outstanding today comes from the market data feed. For Adaptive Biotechnologies it is on record here for 6 fiscal years, 2020 to 2025.

Fiscal years are named for the calendar year they end in.

Cite this page

Funkfolio, “Adaptive Biotechnologies (ADPT) shares outstanding”, data as of 18 November 2026. https://funkfolio.com/stock/ADPT/shares-outstanding

Underlying data: the company's filings with the SEC and Yahoo Finance.